全文获取类型
收费全文 | 7563篇 |
免费 | 533篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 88篇 |
儿科学 | 218篇 |
妇产科学 | 208篇 |
基础医学 | 1055篇 |
口腔科学 | 701篇 |
临床医学 | 532篇 |
内科学 | 1506篇 |
皮肤病学 | 256篇 |
神经病学 | 527篇 |
特种医学 | 176篇 |
外科学 | 848篇 |
综合类 | 23篇 |
一般理论 | 1篇 |
预防医学 | 982篇 |
眼科学 | 91篇 |
药学 | 587篇 |
中国医学 | 71篇 |
肿瘤学 | 240篇 |
出版年
2023年 | 67篇 |
2022年 | 72篇 |
2021年 | 260篇 |
2020年 | 195篇 |
2019年 | 266篇 |
2018年 | 304篇 |
2017年 | 189篇 |
2016年 | 247篇 |
2015年 | 248篇 |
2014年 | 373篇 |
2013年 | 352篇 |
2012年 | 628篇 |
2011年 | 607篇 |
2010年 | 359篇 |
2009年 | 257篇 |
2008年 | 467篇 |
2007年 | 481篇 |
2006年 | 385篇 |
2005年 | 338篇 |
2004年 | 306篇 |
2003年 | 303篇 |
2002年 | 249篇 |
2001年 | 165篇 |
2000年 | 157篇 |
1999年 | 125篇 |
1998年 | 29篇 |
1997年 | 37篇 |
1996年 | 37篇 |
1995年 | 23篇 |
1994年 | 15篇 |
1993年 | 20篇 |
1992年 | 60篇 |
1991年 | 49篇 |
1990年 | 51篇 |
1989年 | 29篇 |
1988年 | 33篇 |
1987年 | 40篇 |
1986年 | 33篇 |
1985年 | 36篇 |
1984年 | 32篇 |
1983年 | 13篇 |
1979年 | 10篇 |
1978年 | 20篇 |
1977年 | 10篇 |
1975年 | 11篇 |
1971年 | 12篇 |
1970年 | 10篇 |
1969年 | 12篇 |
1968年 | 12篇 |
1967年 | 14篇 |
排序方式: 共有8110条查询结果,搜索用时 265 毫秒
1.
Kely Paviani StevanatoRaíssa Bocchi PedrosoCatia Millene Dell AgnoloLander Dos SantosFernando Castilho PellosoMaria Dalva de Barros CarvalhoSandra Marisa Pelloso 《Asian Pacific journal of cancer prevention》2022,23(4):1117-1123
Objective: To perform a scoping review of the applicability of the Gail model in different countries for different ethnicities. Methods: The review was conducted based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist and search strategies based on the PICOS approach. The reviewed articles were included if they were published between 2013 and 2018 in English, Portuguese, or Spanish; were original articles available in full online; and described the use of the Gail model. The PubMed, Embase, and Web of Science data bases were searched. Results: A total of 38 articles eligible for analysis were identified, of which 16 used the Gail model to assess breast cancer risk in women, eight analyzed the applicability of this tool in their population, seven compared the tool and/or modified it according to the specific risk factors of their population, and seven cited the model in determining eligibility for chemoprevention. Conclusion: The Gail model has different applicabilities Greater effectiveness and breast cancer risk are found in developed countries. 相似文献
2.
T.F. Faro E.D. de Oliveira e Silva G.J. Campos N.M. Duarte A.M.M. Caetano J.R. Laureano Filho 《International journal of oral and maxillofacial surgery》2021,50(3):349-355
Throat packs are commonly used in maxillofacial surgeries. However, the evidence to support the benefits of their use is controversial. The aim of this study was to evaluate the effectiveness of throat packs in preventing postoperative nausea and vomiting, and their influence on the incidence of sore throat and dysphagia in patients undergoing orthognathic surgery. This was a prospective double-blind randomized study with 54 patients, who were randomized to two groups: with throat pack (n = 27) and without throat pack (n = 27). Fifty patients (25 in each group) were included in the analysis; 66% female and 34% male, mean age 29.44 ± 8.53 years. Postoperative nausea and vomiting (Kortilla scale), sore throat (visual analogue scale), and dysphagia were evaluated. Statistically significant differences in favour of the without-pack group were found for the variables throat pain at 24 hours (P = 0.002) and dysphagia at 2 hours (P = 0.007) and 24 hours (P < 0.001). There was no difference between the groups regarding postoperative nausea and vomiting (P = 1.00). The results of this study indicate that throat packs as utilized here do not prevent postoperative nausea and vomiting and are associated with worse sore throats and postoperative dysphagia. 相似文献
3.
4.
5.
6.
7.
Otavio Berwanger Renato D. Lopes Diogo D.F. Moia Francisco A. Fonseca Lixin Jiang Shaun G. Goodman Stephen J. Nicholls Alexander Parkhomenko Oleg Averkov Carlos Tajer Germán Malaga Jose F.K. Saraiva Helio P. Guimaraes Pedro G.M. de Barros e Silva Lucas P. Damiani Renato H.N. Santos Denise M. Paisani Tamiris A. Miranda Jose C. Nicolau 《Journal of the American College of Cardiology》2019,73(22):2819-2828
BackgroundThe efficacy of ticagrelor in the long-term post–ST-segment elevation myocardial infarction (STEMI) treated with fibrinolytic therapy remains uncertain.ObjectivesThe purpose of this study was to evaluate the efficacy of ticagrelor when compared with clopidogrel in STEMI patients treated with fibrinolytic therapy.MethodsThis international, multicenter, randomized, open-label with blinded endpoint adjudication trial enrolled 3,799 patients (age <75 years) with STEMI receiving fibrinolytic therapy. Patients were randomized to ticagrelor (180-mg loading dose, 90 mg twice daily thereafter) or clopidogrel (300- to 600-mg loading dose, 75 mg daily thereafter). The key outcomes were cardiovascular mortality, myocardial infarction, or stroke, and the same composite outcome with the addition of severe recurrent ischemia, transient ischemic attack, or other arterial thrombotic events at 12 months.ResultsThe combined outcome of cardiovascular mortality, myocardial infarction, or stroke occurred in 129 of 1,913 patients (6.7%) receiving ticagrelor and in 137 of 1,886 patients (7.3%) receiving clopidogrel (hazard ratio: 0.93; 95% confidence interval: 0.73 to 1.18; p = 0.53). The composite of cardiovascular mortality, myocardial infarction, stroke, severe recurrent ischemia, transient ischemic attack, or other arterial thrombotic events occurred in 153 of 1,913 patients (8.0%) treated with ticagrelor and in 171 of 1,886 patients (9.1%) receiving clopidogrel (hazard ratio: 0.88; 95% confidence interval: 0.71 to 1.09; p = 0.25). The rates of major, fatal, and intracranial bleeding were similar between the ticagrelor and clopidogrel groups.ConclusionAmong patients age <75 years with STEMI, administration of ticagrelor after fibrinolytic therapy did not significantly reduce the frequency of cardiovascular events when compared with clopidogrel. (Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis [TREAT]; NCT02298088) 相似文献
8.
Andrs R. Prez‐Riera Raimundo Barbosa‐Barros Rodrigo Daminello‐Raimundo Luiz Carlos de Abreu Kjell Nikus 《Annals of noninvasive electrocardiology》2019,24(2)
Down syndrome occurs more frequently in the offsprings of older pregnant women and may be associated with atrioventricular septal defect. This refers to a broad spectrum of malformations characterized by a deficiency of the atrioventricular septum and abnormalities of the atrioventricular valves caused by an abnormal fusion of the superior and inferior endocardial cushions with the midportion of the atrial septum and the muscular portion of the ventricular septum. 相似文献
9.
Miku Mislav Benco Nikolina Matak Luka Planini Pavao ori Mario Lovri Helena Radoevi Velena Puevski Tomislav Bajt Mirna Vuji Goran 《Archives of gynecology and obstetrics》2020,301(5):1227-1233
Archives of Gynecology and Obstetrics - To describe a case series of patients with malignant ovarian germ cell tumors (MOGCT) treated exclusively with fertility-sparing surgery (FSS) with or... 相似文献
10.